Dengue shot in final trial


On track: A researcher working in the vaccine laboratory of Panacea Biotec in New Delhi. — AFP

As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world’s first single-dose shots against the deadly mosquito-borne disease.

Dengue, which causes severe flu-like symptoms and debilitating body aches, has exploded globally, fuelled by rising temperatures and densely populated cities.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Indonesia's Bali launches immigration task force to enhance security
Cops detain ex-bus driver, girlfriend over viral 'lap stunt'
Chinese man jailed after trying to smuggle 2,200 ants out of Kenya in his luggage
Australia to raise defence spending to 3% of GDP by 2033
Songkran crowds lift spending across Thailand’s key tourist hubs
Asean News Headlines at 10pm on Wednesday (April 15, 2026)
15 power banks taken from travellers flying out of Singapore's Changi Airport as new two-device rule kicks in
Japan PM pledges US$10bil in financial aid to Asia to tackle oil shortage
Chief Secretary to advise govt on shareholding by civil servants, says Cabinet
Death toll from India's power plant boiler blast rises to 17

Others Also Read